The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.


The Abbott Electrophysiology Solution

Abbott intends to solve one of the most critical and unmet needs in cardiac ablation for atrial fibrillation: better patient outcomes. For the first time, physicians can identify patient-specific sources that sustain serious heart rhythm disorders using the Topera® Rotor Mapping Solution.

The Topera Rotor Mapping Solution provides physicians a diagnostic tool that, for the first time, identifies and locates the unique patient-specific sources, which are believed to be an important sustaining mechanism of cardiac arrhythmias.

Studies that included the identification of rotors as part of the treatment planning have been associated with excellent long-term results.1-5 With the ability to visualize individual rotors, the physician is able to tailor patient-specific treatment approaches, as opposed to the “one size fits all” traditional technique.

By being able to identify specific areas of electrical rotational activity, studies have demonstrated successful use of the Abbott Electrophysiology technology, even in patients who are normally difficult to treat with the traditional procedure.1-8

You have to see it to treat it

With the ability to diagnose the mechanisms of complex cardiac arrhythmias, the Topera Rotor Mapping Solution enables individualized treatment approaches for each patient. By focusing on the precise sources that sustain arrhythmias, Abbott is focused on turning the potential for single treatment freedom from atrial fibrillation (AF or Afib) into reality.

Abbott’s Topera Rotor Mapping Solution includes the FDA-cleared and CE-marked FIRMap® panoramic contact mapping tool and RhythmView® Workstation, which are used in combination to identify and localize the sustaining mechanisms of even the most complex and chaotic cardiac arrhythmias.


Designed with complex arrhythmias and associated heart anatomy in mind, the FIRMap (Focal Impulse and Rotor Modulation) panoramic contact-mapping tool optimizes the clinician’s view of full-chamber, continuous electrical activity. This unique diagnostic catheter is sized to the patient’s chamber, mapping the anatomy from a stable position. Data from the FIRMap catheter is sent to the RhythmView mapping system for processing.


The RhythmView Workstation provides a graphical display of the right and left atrial electrical activity to assist in the identification of rotors and focal impulses to facilitate patient-specific Afib treatment decisions.

  1. Arshad A, Mittal S, Musat D, et al. Long-Term Success From FIRM Ablation is Maintained Even if Acute Endpoint is Not Achieved. Heart Rhythm 2013; 10(P004-133).
  2. Baykaner T, Clopton P, Lalani GG et al. Targeted Ablation at Stable Atrial Fibrillation Sources Improves Success Over Conventional Ablation in High-Risk Patients: A Substudy of the CONFIRM Trial. Canadian J Cardiol 2013; 29:1218-1226.
  3. Miller JM, Krummen DE, Narayan SM et al. Multicenter Validation of Focal Impulse and Rotor Modulation (FIRM) Ablation for Atrial Fibrillation (CONFIRM- Multicenter Validation). AHA Scientific Sessions, Nov 2013; Oral presentation.
  4. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel W-J, Miller J. Treatment of atrial fibrillation by the ablation of localized sources: the conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation: Confirm trial. J Am Coll Cardiol 2012; 60:628– 636.
  5. Narayan SM, Krummen DE, Clopton P, Shivkumar K, and Miller JM. Direct of Coincidental Elimination of Stable Rotors or Focal Sources May Explain Successful AF Ablation: On-Treatment Analysis of the CONFIRM Trial. J Am Coll Cardiol 2013;60(2):138-147.
  6. Chilukuri K, Dalal D, Gadrey S, et al. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(5):521–525.
  7. Hoyer FF, Lickett LM, Mittmann-Braun E, et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol. 2010;29(1):37–41.
  8. Jongnarangsin K, Chugh A, Good E, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 19(7):668-672.